Tatva Chintan Pharma Chem Limited — Important, 02-05-2025: General Updates

Tatva Chintan Pharma Chem reported consolidated revenues of Rs 385 crore and a net profit of Rs 30.35 crore for the year, reflecting robust specialty chemicals operations. The Board has proposed a final dividend of Rs 1 per share (10%). Key auditor appointments were made for FY 2025-26. The company has announced a board meeting to approve the financial results for the quarter and half-year.